ClinicalTrials.gg
RecruitingNCT06471751REMI SAHOSUpdated Nov 18, 2026

Strengthening Inspiratory and Oropharyngeal Muscles in Moderate Obstructive Sleep Apnea Hypopnea Syndrome

An interventional study of Inspiratory and Oropharyngeal Muscle Strengthening in Obstructive Sleep Apnea, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 10 months later.
Updated Sep 25, 2026Primary completion movedStudy completion moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 201 studies in Sleep Apnea, Obstructive with a site in France — 39 open to participants now, 48 under way, 4 of them phase 3. Sleep Apnea, Obstructive · France.

Planned enrollment
82nd of 133
38 · median 52
Started
2024
with 8 others
No phase
105 of 201
18 open now
Primary completion
2027-08
later than 26 of 47 live
Registered
172nd of 201
by date
Lead sponsor
9 of 201
Centre Hospitalier Universitaire de Saint Etienne

Among the 201 studies in Sleep Apnea, Obstructive with a site in France, this one is the 82nd largest by planned enrollment of the 133 interventional ones that give a count, is one of 9 that started in 2024, is one of 105 with no phase, reaches primary completion later than 26 of the 47 other live ones, and was the 172nd registered.

Sleep Apnea, Obstructive

2,245 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

39 of the 201 studies in Sleep Apnea, Obstructive with a site in France are open now. Recruiting first, the newest first:

33 more — sign in →

All 39 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 316 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 123 (39%) stop at 75 or younger; 52 take children under 18; 66 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 201 studies in Sleep Apnea, Obstructive with a site in France, or all of them as a file.
02

Study summary

The Obstructive Sleep Apnea hypopnea Syndrome (OSAS), whose prevalence is 4% of the French population, can lead to serious health consequences (risk of road accidents, onset of cardiovascular disease, etc.). OSAS corresponds to a certain number of interruptions (apneas) or reductions (hypopneas) of ventilation during sleep. The weakening of the tone of the inspiratory and oropharyngeal muscles is one of the main causes of upper airways obstruction during the inspiratory phase.

Read the detailed description

For patients with moderate OSAS, with few or no symptoms, without associated cardiovascular comorbidities, there is no recommended treatment. Rehabilitate the inspiratory and oropharyngeal muscles through muscle strengthening seems to be an alternative to this problem. Therefore, this study proposes a complete rehabilitation care evaluating the effectiveness of the strengthening of inspiratory and oropharyngeal muscles in subject with moderate OSAS.

03

Conditions studied

  • Obstructive Sleep Apnea

Keywords

  • Inspiratory Muscles Training
  • Oropharyngeal training
04

Who can participate

The criteria were revised on the registry on Sep 25, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Moderate SAHOS (15 ≤ AHI ≤30);
  • (BMI) \< 35 ;
  • Patient affiliated or entitled to a social security scheme;
  • Patient having signed a consent to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Excessive daytime sleepiness: Epworth sleepiness score > 10 ;
  • Professional driving and history of accidents related to sleepiness;
  • Severe obstructive or restrictive ventilatory disorders of neuromuscular origin authenticated by respiratory function tests;
  • Patients undergoing treatment for OSAS or requiring immediate initiation of continuous positive airway pressure (CPAP) or a mandibular advancement orthosis;
  • Patients who have stopped CPAP or orthosis treatment in less than one month;
  • Patients undergoing cardiorespiratory exercise rehabilitation or starting regular physical training;
  • Uncompensated heart failure, thoracic sternotomy surgery \< 4 months;
  • Marked osteoporosis with history of rib fractures;
  • History of spontaneous pneumothorax;
  • Severe asthma;
  • Perforated eardrum or any other ear condition;
  • Pulmonary hypertension;
  • History of pharyngeal surgery to treat sleep apnea;
  • Pregnant women or women in labor;
  • Individuals deprived of their liberty or hospitalized without consent;
  • Adults subject to legal protective measures (guardianship or conservatorship).

for MRI

  • Patient with claustrophobia;
  • Patient for whom MRI is contraindicated (pacemaker, metallic heart valve, metallic foreign body in the eye).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
38 participants (estimated)

Study arms

  • Experimental
    Strengthening muscles group

    Home training to strengthen Inspiratory and Oropharyngeal muscles

    Other: Inspiratory and Oropharyngeal Muscle Strengthening

  • No intervention
    No training group

    No intervention

Interventions

  • OtherInspiratory and Oropharyngeal Muscle Strengthening

    Patients will conduct the training at home, 5 days a week for 3 months. They will perform 2 sets of 30 inspirations against resistance (POWERbreathe® K5 , Powerbreathe International Limited, UK), equal to 70% Maximum Inspiratory Pressure (MIP). Patients will be guided for oropharyngeal exercises. The sessions will be supervised by the investigator every 3 weeks. During sessions with the investigator, sessions recorded in the device will be downloaded to verify compliance. A MIP measurement will be performed to adjust the resistance of the device.

06

What researchers measure

Primary outcomes

  1. Apnea-Hypopnea Index (AHI)

    AHI is measured by polygraphy or polysomnography. It is not a score

    Time frame: At 3 months

Secondary outcomes

  1. Maximum inspiratory pressure measurement (cmH2O)

    Measured by POWERbreathe® K5

    Time frame: At 3 and 9 Months

  2. Neck circumference (cm)

    The neck circumference is measured by Magnetic Resonance Imagery (RMI)

    Time frame: At 3 months

  3. Epworth sleepiness score

    Sleep quality assessment using the Epworth sleepiness score. From 0 to 24. If score up to 10 then the patient has signs of excessive daytime sleepiness

    Time frame: At 3 and 9 Months

  4. Pittsburgh Sleep quality index

    Sleep quality assessment using the Pittsburgh Sleep quality index. From 0 to 21. Score 0 = very good sleep quality. Score 21 = very poor sleep quality

    Time frame: At 3 and 9 Months

  5. Quality of life scale : Short Form 12 (SF12)

    Quality of life assessment using the scale SF12 From 43 to 118 the higher the score, the better the quality of life

    Time frame: At 3 and 9 Months

  6. PICOT fatigue scale

    Fatigue assessment using the PICOT scale From 0 to 32 If score up to 22 then the patient has signs of excessive sleepiness

    Time frame: At 3 and 9 Months

  7. AHI (Apnea-Hypopnea Index)

    AHI is measured by polygraphy or polysomnography It is not a score

    Time frame: At 9 months

07

Study locations

1 of 2 sites recruiting
  • CHU de Grenoble
    Grenoble, 38000, France
    Not yet recruiting
    • Sébastien BAILLIEUL, MD · Principal investigator
  • Centre Hospitalier Universitaire
    Saint-Etienne, 42055, France
    Recruiting
    • Amandine ZELLAG, physiotherapist · Principal investigator
    • Pierre LABEIX, physiotherapist · Sub investigator
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified individual participant data underlying the results reported in the manuscript

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Beginning 6 months following publication and ending 5 years after publication

Access criteria: Data will be available upon reasonable request to the corresponding author for scientifically sound proposals

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for Aug 2027, 31 months after the start.

Of 510 non-industry interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 31 months is close to that.

Counting every sponsor, half of 628 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 25, 2026: primary completion Aug 2026 → Aug 2027 and completion Aug 2026 → Aug 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 18, 2024
First posted
Jun 24, 2024
StartActual
Dec 30, 2024
Primary completionEst.
Aug 1, 2027was Aug 2026
CompletionEst.
Aug 1, 2027was Aug 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • Centre Hospitalier Universitaire · Saint-Etienne, France
Show 1 removed
  • Centre Hospitalier Universitaire · Saint-Étienne, France
Sep 25, 2026
Primary completion
Aug 1, 2026→Aug 1, 2027
Sep 25, 2026
Study completion
Aug 1, 2026→Aug 1, 2027
Sep 25, 2026
Eligibility
9 exclusion criteria added
What changed in the criteria
Exclusion criteria
  • AddedPerforated eardrum or any other ear condition;
  • AddedPulmonary hypertension;
  • AddedHistory of pharyngeal surgery to treat sleep apnea;
  • AddedPregnant women or women in labor;
  • AddedIndividuals deprived of their liberty or hospitalized without consent;
  • AddedAdults subject to legal protective measures (guardianship or conservatorship).
  • AddedContraindications for MRI
  • AddedPatient with claustrophobia;
  • AddedPatient for whom MRI is contraindicated (pacemaker, metallic heart valve, metallic foreign body in the eye).
Sep 25, 2026
Show all 2 updates
  1. Nov 18, 2026
    Minor edits only
    + 2 other changes: verification date and data sharing statement
  2. Sep 25, 2026
    1 site added, 1 site removed
    Show site
    • Centre Hospitalier Universitaire · Saint-Etienne, France
    Show 1 removed
    • Centre Hospitalier Universitaire · Saint-Étienne, France
    Primary completion Aug 1, 2026→Aug 1, 2027
    Study completion Aug 1, 2026→Aug 1, 2027
    Eligibility 9 exclusion criteria added
    What changed in the criteria
    Exclusion criteria
    • AddedPerforated eardrum or any other ear condition;
    • AddedPulmonary hypertension;
    • AddedHistory of pharyngeal surgery to treat sleep apnea;
    • AddedPregnant women or women in labor;
    • AddedIndividuals deprived of their liberty or hospitalized without consent;
    • AddedAdults subject to legal protective measures (guardianship or conservatorship).
    • AddedContraindications for MRI
    • AddedPatient with claustrophobia;
    • AddedPatient for whom MRI is contraindicated (pacemaker, metallic heart valve, metallic foreign body in the eye).
    + 3 other changes: index terms, verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06471751
Collaborators
Association aide à la recherche médicale de proximité (AIRE), Conseil national de l'ordre des masseurs-kinésithérapeutes
Responsible party
Sponsor
First posted
Jun 24, 2024
Start date
Dec 30, 2024
Primary completion
Aug 1, 2027 (estimated)
Completion
Aug 1, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Amandine ZELLAG, physiotherapist
Contact
amandine.zellag@chu-st-etienne.fr
(0)4 77 12 73 93 ext. +33
Pierre LABEIX, physiotherapist
Contact
pierre.labeix@chu-st-etienne.fr
Amandine Zellag
principal investigator · Centre Hospitalier Universitaire de Saint Etienne

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion